Registration Dossier

Diss Factsheets

Administrative data

Endpoint:
short-term repeated dose toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Data from the MSDS of the Supplier.

Data source

Reference
Reference Type:
secondary source
Title:
Unnamed
Year:
2011
Report date:
2001

Materials and methods

Principles of method if other than guideline:
No data
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
(2Z)-3-amino-1-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)but-2-en-1-one
EC Number:
616-378-0
Cas Number:
767340-03-4
Molecular formula:
C16H13F6N5O
IUPAC Name:
(2Z)-3-amino-1-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)but-2-en-1-one
Test material form:
not specified

Test animals

Species:
rat
Strain:
not specified

Administration / exposure

Route of administration:
oral: unspecified
Vehicle:
not specified

Results and discussion

Results of examinations

Details on results:
the only finding was an increase in liver weights

Effect levels

Dose descriptor:
NOEL
Effect level:
150 mg/kg bw/day (nominal)
Based on:
not specified
Sex:
not specified
Basis for effect level:
other: the only finding was an increase in liver weights

Target system / organ toxicity

Critical effects observed:
not specified

Applicant's summary and conclusion